aTyr Pharma Inc (LIFE)
1.60
-0.02
(-1.23%)
USD |
NASDAQ |
Apr 24, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Enterprise Value: 11.40M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 11.40M |
| April 22, 2024 | 12.76M |
| April 19, 2024 | 10.05M |
| April 18, 2024 | 11.40M |
| April 17, 2024 | 9.368M |
| April 16, 2024 | 10.72M |
| April 15, 2024 | 16.82M |
| April 12, 2024 | 19.53M |
| April 11, 2024 | 20.89M |
| April 10, 2024 | 21.56M |
| April 09, 2024 | 18.18M |
| April 08, 2024 | 25.63M |
| April 05, 2024 | 27.66M |
| April 04, 2024 | 28.34M |
| April 03, 2024 | 26.98M |
| April 02, 2024 | 26.31M |
| April 01, 2024 | 31.05M |
| March 28, 2024 | 33.76M |
| March 27, 2024 | 37.15M |
| March 26, 2024 | 31.39M |
| March 25, 2024 | 31.73M |
| March 22, 2024 | 33.76M |
| March 21, 2024 | 38.50M |
| March 20, 2024 | 38.50M |
| March 19, 2024 | 37.15M |
| Date | Value |
|---|---|
| March 18, 2024 | 34.10M |
| March 15, 2024 | 36.47M |
| March 14, 2024 | 11.40M |
| March 13, 2024 | 12.08M |
| March 12, 2024 | 4.17M |
| March 11, 2024 | 2.904M |
| March 08, 2024 | 2.271M |
| March 07, 2024 | 6.701M |
| March 06, 2024 | 9.233M |
| March 05, 2024 | 7.334M |
| March 04, 2024 | 14.93M |
| March 01, 2024 | 22.52M |
| February 29, 2024 | 23.16M |
| February 28, 2024 | 21.89M |
| February 27, 2024 | 28.22M |
| February 26, 2024 | 24.42M |
| February 23, 2024 | 22.52M |
| February 22, 2024 | 21.26M |
| February 21, 2024 | 26.32M |
| February 20, 2024 | 20.62M |
| February 16, 2024 | 29.48M |
| February 15, 2024 | 23.47M |
| February 14, 2024 | 23.16M |
| February 13, 2024 | 22.52M |
| February 12, 2024 | 26.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-37.32M
Minimum
Nov 14 2023
301.48M
Maximum
Sep 23 2021
13.10M
Average
3.045M
Median
Jul 25 2023
Enterprise Value Benchmarks
| Vaxart Inc | 89.83M |
| Allogene Therapeutics Inc | 121.14M |
| AIM ImmunoTech Inc | 8.852M |
| Protalix BioTherapeutics Inc | 63.35M |
| Armata Pharmaceuticals Inc | 160.23M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.76M |
| Total Expenses (Quarterly) | 15.96M |
| EPS Diluted (Quarterly) | -0.25 |
| Earnings Yield | -60.00% |
| Normalized Earnings Yield | -60.62 |